Manolo Carta, Ph.D.
|2010-||Biomedical Sciences||Cagliari University|
Mean distance: 15.36 (cluster 11)
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Scheggi S, Rossi F, Corsi S, et al. (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease|
|Meloni M, Puligheddu M, Sanna F, et al. (2020) Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869|
|Fanni S, Scheggi S, Rossi F, et al. (2018) 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130|
|Tronci E, Napolitano F, Muñoz A, et al. (2017) BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology|
|Frau R, Savoia P, Fanni S, et al. (2017) The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology|
|Pinna A, Ko WK, Costa G, et al. (2016) Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society|
|Ghiglieri V, Mineo D, Vannelli A, et al. (2016) Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. Neurobiology of Disease. 86: 140-53|
|Fanni S, Frau R, Tronci E, et al. (2016) P.2.018 Role of 5-alpha reductase in the pathophysiology of L-DOPA induced dyskinesia European Neuropsychopharmacology. 26: S38-S39|
|Tronci E, Fidalgo C, Carta M. (2015) Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia. Parkinson's Disease. 2015: 563820|
|Bastide MF, Meissner WG, Picconi B, et al. (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology|